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To identify molecular mechanisms underlying the prospective
health advantages associated with psychological well-being, we
analyzed leukocyte basal gene expression profiles in 80 healthy
adults who were assessed for hedonic and eudaimonic well-being,
as well as potentially confounded negative psychological and
behavioral factors. Hedonic and eudaimonic well-being showed
similar affective correlates but highly divergent transcriptome
profiles. Peripheral blood mononuclear cells from people with
high levels of hedonic well-being showed up-regulated expression
of a stress-related conserved transcriptional response to adversity
(CTRA) involving increased expression of proinflammatory genes
and decreased expression of genes involved in antibody synthesis
and type I IFN response. In contrast, high levels of eudaimonic
well-being were associated with CTRA down-regulation. Pro-
moter-based bioinformatics implicated distinct patterns of tran-
scription factor activity in structuring the observed differences
in gene expression associated with eudaimonic well-being (re-
duced NF-κB and AP-1 signaling and increased IRF and STAT signal-
ing). Transcript origin analysis identified monocytes, plasmacytoid
dendritic cells, and B lymphocytes as primary cellular mediators of
these dynamics. The finding that hedonic and eudaimonic well-be-
ing engage distinct gene regulatory programs despite their similar
effects on total well-being and depressive symptoms implies that
the human genome may be more sensitive to qualitative variations
in well-being than are our conscious affective experiences.
social genomics | gene regulation
Psychological well-being has been shown to forecast futurephysical health above and beyond its association with current
physical health (1–6), and above and beyond its association with
reduced levels of stress, depression, and other negative affective
states (2, 3, 5–11). However, the biological basis for this re-
lationship remains poorly understood, in part because of a pau-
city of information regarding the molecular signaling pathways
that transduce positive psychological states into somatic physi-
ology (12), and in part because of the multidimensional nature of
human well-being (6, 13).
Philosophers have long distinguished two basic forms of well-
being: a “hedonic” form representing the sum of an individual’s
positive affective experiences, and a deeper “eudaimonic” form
that results from striving toward meaning and a noble purpose
beyond simple self-gratification (6, 13–16). Both dimensions of
well-being are deeply implicated in human biology and evolution
(17–24), with hedonic well-being hypothesized to motivate basic
physiological and psychological adaptations, and eudaimonic
well-being hypothesized to motivate more complex social and
cultural capacities (17–19, 25, 26). Although hedonic and
eudaimonic well-being are conceptually distinct, they are em-
pirically correlated (14, 27) and can reciprocally influence each
other (28, 29). As a result, it has been difficult to determine from
observational epidemiology which form of human well-being is
most directly related to physical health and longevity (6). It has
also been difficult to determine whether hedonic and eudaimonic
well-being engage similar biological processes, or whether they
have distinct physiologic consequences (although refs. 13, 30,
and 31 provide some initial explorations).
In the present study, we examined the biological implications
of hedonic and eudaimonic well-being through the lens of the
human genome—a system of ∼21,000 genes that has evolved
fundamentally to help humans survive and thrive (i.e., be well)
(32). Previous studies have found that circulating immune cells
show a systematic shift in basal gene expression profiles during
extended periods of stress, threat, or uncertainty (12, 33). This
conserved transcriptional response to adversity (CTRA) is
characterized by increased expression of genes involved in in-
flammation (e.g., proinflammatory cytokines such as IL1B, IL6,
IL8, and TNF) and decreased expression of genes involved in
type I IFN antiviral responses (e.g., IFI-, OAS-, and MX- family
genes) and IgG1 antibody synthesis (e.g., IGJ) (12, 33–35). The
CTRA transcriptional program likely evolved to help the im-
mune system counter the changing patterns of microbial threat
ancestrally associated with changing socioenvironmental con-
ditions (e.g., increased risk of wound-related bacterial infection
associated with experienced threat or social conflict vs. increased
risk of socially mediated viral infection associated with affine
social contact) (12, 33, 36). However, in the very different en-
vironment of contemporary human society, chronic CTRA ac-
tivation by social or symbolic threats may promote inflammation-
mediated cardiovascular, neurodegenerative, and neoplastic
diseases and impair host resistance to viral infections (12, 33, 37).
The present analysis used the CTRA gene expression profile as
a high-dimensional molecular reference space in which to map
the potentially distinct biological effects of hedonic and eudai-
monic well-being.
Results
Differential expression of the leukocyte CTRA was assessed
in genome-wide transcriptional profiles of peripheral blood
mononuclear cells (PBMCs) sampled from 80 healthy adults
recruited from the Chapel Hill, NC, area and assessed for hedonic
and eudaimonic well-being. Table 1 reports sample characteristics
and correlates of each dimension of well-being. Individuals dif-
fered widely in their levels of hedonic and eudaimonic well-being,
with status varying across the majority of the assessment instru-
ment’s six-point frequency metric (Short Flourishing Scale) (38)
(Fig. 1A). As previously observed (6, 14, 27), hedonic and eudai-
monic well-being were positively correlated (r = 0.79; P < 0.0001).
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Average levels of hedonic well-being exceeded average levels of
eudaimonic well-being across the sample as a whole (hedonic,
mean = 3.75 ± 0.11 SEM; eudaimonic, 3.17 ± 0.12; difference, P <
0.0001). Only 22% of study participants showed levels of eudai-
monic well-being that exceeded their level of hedonic well-being
(i.e., eudaimonic predominance; sign test, P < 0.0001; Fig. 1B).
Negative Affective Correlates of Well-Being. Hedonic and eudai-
monic well-being may potentially engage different levels of
negative affect as a result of eudaimonic subordination of he-
donic self-gratification (6, 14). However, analyses found both
forms of well-being to show similarly strong inverse relationships
to symptoms of depression [Center for Epidemiological Studies–
Depression (CES-D) correlation with hedonic well-being, r = −0.67,
P < 0.0001; correlation with eudaimonic well-being, r = −0.66,
P < 0.0001; difference in dependent correlations, P = 0.8550].
Similarly strong inverse relationships were also observed for
CES-D subscales assessing affective symptoms of depression
(hedonic, r = −0.75, P < 0.001; eudaimonic, r = −0.71, P < 0.001;
difference, P = 0.3228) and vegetative symptoms of depression
(hedonic, r = −0.45, P < 0.001; eudaimonic, r = −0.48, P < 0.001;
difference, P = 0.6297).
CTRA Transcriptome Profile. Primary analyses examined the rela-
tionships of hedonic and eudaimonic well-being to expression of
a 53-gene contrast score summarizing three a priori-defined
components of the CTRA profile (12, 33–35): up-regulated ex-
pression of proinflammatory genes, down-regulated expression
of genes mediating type I IFN responses, and down-regulated
expression of genes involved in antibody synthesis. General lin-
ear model analyses quantified the association between expres-
sion of each of the 53 CTRA contrast genes and levels of hedonic
and eudaimonic well-being [each well-being dimension treated as
a continuous measure and adjusted for correlation with the other
dimension of well-being and for age, sex, race/ethnicity, body
mass index (BMI), smoking, alcohol consumption, recent minor
illness symptoms, and leukocyte subset prevalence; SI Methods].
Contrast coefficient-weighted association statistics were averaged
to summarize the magnitude of association over the entire CTRA
gene set. CTRA gene expression varied significantly as a function
of eudaimonic and hedonic well-being (Fig. 2A). As expected based
on the inverse association of eudaimonic well-being with de-
pressive symptoms, eudaimonic well-being was associated with
down-regulated CTRA gene expression (contrast, P = 0.0045).
In contrast, CTRA gene expression was significantly up-regu-
lated in association with increasing levels of hedonic well-being
(P = 0.0047). Follow-up analysis of specific gene subsets linked
higher levels of eudaimonic well-being to up-regulated expres-
sion of type I IFN response genes (P = 0.0084) and a trend to-
ward up-regulated expression of antibody synthesis genes (P =
0.0849; Fig. 2B). In contrast, higher levels of hedonic well-being
were associated with up-regulated expression of proinflam-
matory genes (P = 0.0008) and a trend toward down-regulated
expression of antibody synthesis genes (P = 0.0776; Fig. 2B).
To ensure that differential gene expression estimates were not
distorted by the high correlation of hedonic and eudaimonic
well-being (39), we conducted ancillary analyses in which the 2D
well-being space was reparameterized in terms of total well-being
(i.e., hedonic plus eudaimonic) and relative eudaimonic pre-
dominance (i.e., eudaimonic minus hedonic). These reparame-
terized dimensions were only modestly correlated (r = 0.21; P =
0.0610; Fig. 1B). Simultaneous analysis of both reparameterized
dimensions showed no differential expression of the CTRA
profile as a function of total well-being (mean = −0.54 ± 2.93%
difference in contrast gene expression over the range [−2 SD, +2
SD] relative to mean level of total well-being; P = 0.8530).
However, eudaimonic predominance was associated with signif-
icant down-regulation of the CTRA gene expression profile
(−4.52 ± 1.27% over [−2 SD, +2 SD]; P = 0.0010). The latter
effect stemmed primarily from down-regulation of pro-
inflammatory genes (−8.50 ± 3.45% over [−2 SD, +2 SD];
P = 0.0016).
Transcription Control Pathways. To assess the role of immuno-
regulatory transcription factors previously implicated in CTRA-
related gene expression (proinflammatory NF-κB and activator
protein 1 (AP-1) factors and type I IFN-related STAT and in-
terferon response factor (IRF) factors) (12, 33–35), we applied
Transcription Element Listening System (TELiS) promoter-
based bioinformatics analyses (40) to all genes showing ≥1.5-fold
difference in average expression over the range from −2 SD to +
2 SD relative to the sample mean on each dimension of well-
being (hedonic, 92 transcripts up-regulated and 52 down-regu-
lated; eudaimonic, 65 up-regulated and 123 down-regulated;
genes listed in Datasets S1 and S2). Analyses of genes regulated
in association with eudaimonic well-being indicated up-regulated
Table 1. Sample characteristics
Characteristic Value
r (P value) for association*
With Hedonic With Eudaimonic
Age, y 48.1 ± 8.1 +0.02 (0.8545) −0.01 (0.9447)
Female sex, % 60.0 +0.01 (0.9481) +0.02 (0.8663)
Race/ethnicity, % — NA (0.1592)† NA (0.3536)†
White 61.5 — —
Black 30.1 — —
Hispanic 3.6 — —
Asian 4.8 — —
Body mass index, kg/m2 28.8 ± 7.1 −0.22 (0.0433) −0.17 (0.2073)
Smoking history, % 15.7 −0.05 (0.6869) +0.05 (0.6470)
Alcohol history, % 64.2 +0.18 (0.1045) +0.07 (0.5540)
Depression (CES-D), 0–60 scale 12.8 ± 10.5 −0.65 (0.0001) −0.64 (0.0001)
Minor illness symptoms, 0–8 scale‡ 0.9 ± 0.9 −0.20 (0.0757) −0.27 (0.0222)
Values presented as mean ± SD where appropriate. NA, not applicable.
*P value for simple (unadjusted) association (r or F).
†P values derive from one-way ANOVA testing for differences in eudaimonic and hedonic well-being as a func-
tion of race/ethnic group.
‡Frequency of 13 minor illness symptoms during the previous 2 wk, each rated from 0 (not at all) to 8 (very
frequently).
























activity of IRF and STAT family transcription factors and mar-
ginally down-regulated activity of NF-κB and AP-1 factors (Fig.
3A). However, none of these basic immunoregulatory tran-
scription factors was implicated in the transcriptional effects of
hedonic well-being (Fig. 3A). Transcription factor results were
shown to be reliable in split-half replication studies (r = 0.71) and
Monte Carlo analyses of statistical power and result replicability
(Figs. S1–S5).
Cellular Origins. To determine whether the transcriptional corre-
lates of well-being might occur within the same leukocyte sub-
populations previously shown to mediate the CTRA transcriptional
effects of adverse experience (i.e., monocytes, dendritic cells, and
B lymphocytes) (34–36, 41, 42), we conducted transcript origin
analysis (TOA) (36) on differentially expressed genes (Datasets S1
and S2). Results identified monocytes and plasmacytoid dendritic
cells (pDCs) as primary carriers of genes up-regulated in hedonic
well-being and primary carriers of genes down-regulated in eudai-
monic well-being (Fig. 3B). B lymphocytes predominately con-
tributed genes down-regulated in hedonic well-being and genes
up-regulated in eudaimonic well-being. Results of cellular origin
analyses were found to be reliable in split-half replication studies
(r = 0.82 for eudaimonic association and r = 0.79 for hedonic; Figs.
S6 and S7) and in Monte Carlo analyses of statistical power and
result replicability (Figs. S1–S5).
Discussion
The results of this study show that hedonic and eudaimonic well-
being, although correlated, have markedly divergent gene tran-
scriptional correlates in human immune cells. Eudaimonic well-
being was associated with decreased expression of the previously
defined CTRA transcriptome profile involving elevated expres-
sion of proinflammatory genes and reduced expression of genes
involved in antibody synthesis and type I IFN antiviral responses
(12, 33–35). In contrast, hedonic well-being was associated with
significant up-regulation of the CTRA gene expression profile.
These opposing transcriptome profiles emerged despite the fact
that hedonic and eudaimonic well-being were experienced sim-
ilarly at the level of conscious affect (i.e., they showed compa-
rably strong positive relationships to total well-being and
comparably strong inverse relationships to depressive symptoms,
and were highly correlated with one another). The observed
differences in gene expression were also independent of de-
mographic, health, and behavioral risk factors (age, sex, race/
ethnicity, BMI, smoking, alcohol consumption, minor illness
symptoms), independent of variation in the distribution of leu-
kocyte subsets within the circulating PBMC pool, and robust to
reparameterization of the 2D well-being space to mitigate the
collinearity of hedonic and eudaimonic well-being. In repar-
ameterized analyses, CTRA gene expression did not vary as
a function of total well-being (hedonic plus eudaimonic), but it
was significantly down-regulated among individuals showing
a relative predominance of eudaimonic vs. hedonic well-being.
The emergence of distinct leukocyte transcriptome profiles in the
presence of similar affective profiles suggests that the gene reg-
ulatory architecture of the human immune system may be more
sensitive to the eudaimonic vs. hedonic sources of human hap-
piness than are our conscious experiences.
Bioinformatic analyses of the gene expression differences as-
sociated with hedonic vs. eudaimonic well-being implicated
several of the same cellular mediators and transcription control
pathways previously linked to CTRA activation in adverse life cir-
cumstances such as low socioeconomic status, social isolation, di-
agnosis with a life-threatening disease, and imminent bereavement
Fig. 1. (A) Relationship between hedonic and eudaimonic well-being (dashed line indicates equivalent levels; n = 80). (B) Tukey mean-difference plot (39)
reexpressing individual differences in well-being in terms of total well-being (hedonic plus eudaimonic) and eudaimonic predominance (eudaimonic minus
hedonic; dashed line indicates equivalent levels).
Fig. 2. Expression of the CTRA gene set. (A) Linear model-based estimates
of mean difference (±SEM) in expression in a 53-gene CTRA contrast score in
PBMCs from individuals with low levels (−2 SD relative to sample mean) vs.
high levels (+2 SD) of hedonic well-being and eudaimonic well-being (each
adjusting for the other and for demographic and behavioral covariates). (B)
Differential expression of CTRA subcomponents: 19 proinflammatory genes,
31 type I IFN response genes, and three antibody synthesis genes.
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(12, 33–35). In promoter-based bioinformatics analyses of tran-
scription factor activity, eudaimonic well-being showed a regulatory
profile inverse to that previously associated with adverse life cir-
cumstances (i.e., reversal of CTRA-related up-regulation of proin-
flammatory NF-κB and AP-1 transcription factors and down-
regulation of antiviral IRF and STAT factors) (12, 33–35). How-
ever, none of these basic immunoregulatory transcription factors
was implicated in the transcriptomic effects of hedonic well-being.
Transcript origin analyses also identified monocytes, pDCs, and B
lymphocytes as cellular mediators of well-being’s effects on gene
expression, but in a reciprocal pattern for its hedonic and eudai-
monic dimensions (i.e., monocytes and pDCs were implicated in
eudaimonic gene down-regulation, and monocytes and B lympho-
cytes were implicated in eudaimonic gene up-regulation). In con-
junction with the analyses of transcription factor activity, these
results suggest that the divergent gene expression profiles observed
in hedonic and eudaimonic well-being are mediated by activation of
distinct receptor systems within a fixed set of environmentally re-
sponsive cell types (33). These findings mirror results from previous
studies of adverse experience in identifying a similar set of target
cells (34, 36, 41, 42), with eudaimonic well-being in particular
showing a reversal of CTRA-related transcription factor dynamics
(12, 33). These results identify specific psychological, cellular, and
molecular targets for future analyses of the social signal trans-
duction pathways that mediate the prospective health advantages of
psychological well-being (1–11).
In interpreting these results, it is important to note that he-
donic and eudaimonic well-being are not mutually exclusive
approaches to happiness, nor do they represent a simple typology
or a tradeoff. Both types of well-being share some common
sources (e.g., perceived social connections) (29) and can re-
ciprocally influence one another (29) [i.e., positive affect pre-
disposes people to find positive meaning (43, 44), and finding
positive meaning increases positive affect (45)]. As such, the
current finding that a purified index of eudaimonic well-being
(purged of shared variance with hedonia) predicts a more fa-
vorable pattern of gene expression than does a purified index of
hedonic well-being (purged of shared variance with eudaimonia)
says more about which form of well-being one would not want to
do without, rather than which form one would be better to avoid.
For people in whom one form of well-being outweighs the other,
striving predominately toward meaning may have more favorable
effects on health than striving predominately toward positive
affect per se. An important topic for future research will be to
define which specific sources of well-being are most generative of
eudaimonia and health (e.g., social pleasures such as connecting
with others, cognitive pleasures such as taking in new ideas,
spiritual pleasures such as connecting to something larger than
the self, and creative pleasures such as generating new knowl-
edge or works of art) (13, 15).
The present findings are limited in several respects. These
results come from a cross-sectional analysis, and the observed
associations may reflect a causal effect of immune biology on
affect or social behavior (46, 47). However, that is unlikely to
explain the associations observed here because experimentally
induced inflammation generally reduces hedonic well-being (6,
46, 47) whereas these findings link inflammatory gene expression
to elevated hedonic well-being. Nevertheless, direct experimen-
tal manipulations of hedonic and eudaimonic well-being will be
required to clearly define their causal effects. No direct measure
of immune system functional activity is available here (e.g., ef-
fector response to an immunologic challenge), so the health
significance of these gene expression dynamics remains to be
determined. However, the observed up-regulation of antibody
synthesis genes in eudaimonic well-being is consistent with pre-
vious data showing enhanced antibody response to vaccination in
people with high levels of well-being (48, 49). The observed
down-regulation of proinflammatory genes in eudaimonic well-
being is also consistent with previous studies of protein bio-
markers of inflammation and other cardiovascular risk factors (6,
13, 30, 31, 50, 51). This study focuses on a one-time analysis of
immune cell gene expression in a predominately white US
sample, and replication of these findings in other populations
with longitudinal assessment of well-being and biology will be
required to gauge generality and consistency of these effects. In
the context of the present sample, split-half replication studies
and Monte Carlo power analyses indicated that the observed
associations involving specific a priori-defined gene sets are re-
liable (Figs. S1–S3, S6, and S7). This study was not designed for
de novo discovery of reliable associations between specific in-
dividual transcripts and well-being phenotypes. The low-level
point estimates of association in Datasets S1 and S2 serve only as
inputs into high-level bioinformatics analyses of CTRA-related
cell types and transcription factors, and should not be considered
statistically reliable at the individual gene level. The high-level
bioinformatic results emerging from these analyses are consistent
with previous direct assays of target cell type and transcription
factor activity (12, 33), but the present results require direct
verification in future studies. The gene expression dynamics
observed here can only be interpreted in the context of immune
Fig. 3. Transcription control pathways and cellular origin. Genes showing ≥1.5-fold differential expression across low levels (−2 SD relative to sample mean)
vs. high levels (+2 SD relative to sample mean) of eudaimonic well-being and hedonic well-being were tested for (A) differential activity of specific tran-
scription factors as indicated by TELiS analysis of transcription factor-binding motifs (TFBM) in proximal promoter sequences of up- vs. down-regulated genes
(40) and (B) PBMC cell type of origin as indicated by TOA cell-type diagnosticity z-scores (36). (*P < 0.05 after control for multiple hypothesis testing.)
























cells, and the effects of well-being on transcriptomes in the
central nervous system and other tissues remains an important
topic for future research. The measure of well-being used here
provides valid and reliable assessments of general hedonic and
eudaimonic well-being (38, 52) (e.g., in this sample, Cronbach α
values are 0.93 and 0.92 for those two respective domains), but
defining the specific aspects of eudaimonia that relate most di-
rectly to gene expression [e.g., as has been done for other health-
related biomarkers (13, 30, 31)] will require more extensive
measurement of the constituent dimensions of eudaimonia in
future studies (13, 15, 30, 53).
Hedonic and eudaimonic well-being were originally distin-
guished to resolve basic and ancient philosophical questions re-
garding the best way for humans to live (14, 16, 53, 54). The
present data offer little grounds to prefer one mode of happiness
over the other based on affective experience, but they identify
a stark contrast at the level of molecular physiology. If “the good
life” is a long and healthy life free from the allostatic load of
chronic stress, threat, and uncertainty (55, 56), CTRA gene ex-
pression may provide a negative reference point for how not to
live [figuratively in its association with adverse experience (12, 33)
and literally in its expression of disease-promoting genes (37)]. If
we ask which type of happiness most directly opposes that mo-
lecular antipode, a functional genomic perspective favors eu-
daimonia. Genomics-based analyses also reveal an adverse
molecular physiology of hedonic well-being that appears not to
register at the level of experienced affect. This dissociation of
molecular well-being from affective well-being implies the poten-
tial for an objective approach to moral philosophy rooted in the
utility of health and the basic biology of human nature (57–59) as
revealed in 2 million years of evolved genomic programming to
help human beings survive and thrive in this world (32).
Methods
Participants and Study Procedure. A total of 84 healthy adults were recruited
from the Durham and Orange County regions of North Carolina by com-
munity-posted flyers and e-mail advertisements followed by telephone
screening to assess eligibility criteria, including age 35 to 64 y, written and
spoken English, and absence of chronic illness or disability. Following written
informed consent, participants completed online assessments of hedonic and
eudaimonic well-being [Short Flourishing Scale, e.g., in the past week, how
often did you feel. . . happy? (hedonic), satisfied? (hedonic), that your life has
a sense of direction or meaning to it? (eudaimonic), that you have experi-
ences that challenge you to grow and become a better person? (eudai-
monic), that you had something to contribute to society? (eudaimonic);
answered on a six-point frequency metric whereby 0 indicates never, 1
indicates once or twice, 2 indicates approximately once per week, 3 indicates
two or three times per week, 4 indicates almost every day, and 5 indicates
every day] (38, 52) and depressive symptoms (per CES-D) (60), and then
attended a late-afternoon laboratory session in which they were assessed for
weight, height, and blood pressure, and provided a 20-mL venipuncture
blood sample under resting conditions. Age, sex, race/ethnicity, smoking
history, alcohol consumption, and 2-wk history of 13 minor illness symptoms
(e.g., headache, upset stomach) were assessed as potential confounders.
Unless otherwise indicated, all statistical results derive from generalized
linear model analyses (61). All study procedures were approved by the in-
stitutional review board of the University of North Carolina at Chapel Hill.
Transcriptome Analysis. Genome-wide transcriptional profiling was carried
out on isolated PBMCs from all 80 participants who provided blood samples.
Assays were conducted as previously described (36, 62), with PBMCs isolated
by density gradient centrifugation and total RNA extracted (RNeasy; Qia-
gen), tested for suitable mass (Nanodrop ND1000) and integrity (Bio-
analyzer; Agilent), and converted to fluorescent cRNA for hybridization to
Illumina Human HT-12 v4 BeadArrays following the manufacturer’s standard
protocol in the University of California, Los Angeles, Neuroscience Genomics
Core Laboratory. Quantile-normalized gene expression values (Gene Ex-
pression Omnibus series GSE45330) were transformed to log2 for general
linear model analyses quantifying association of transcript abundance with
continuous (z-score) measures of hedonic and eudaimonic well-being (each
controlling for the other) while also controlling for age, sex, race/ethnicity,
BMI, alcohol consumption, smoking, and minor illness symptoms. To ensure
that results were not confounded by individual differences in the prevalence
of specific leukocyte subtypes within the PBMC pool (63), analyses also
controlled for the prevalence of transcripts marking T lymphocyte subsets
(CD3D, CD3E, CD4, CD8A), B lymphocytes (CD19), natural killer cells (CD16/
FCGR3A, CD56/NCAM1), and monocytes (CD14) (64). Primary analyses fo-
cused on an a priori-defined contrast score representing the CTRA profile of
up-regulated expression of proinflammatory genes (IL1A, IL1B, IL6, IL8, TNF,
PTGS1, PTGS2, FOS, FOSB, FOSL1, FOSL2, JUN, JUNB, JUND, NFKB1, NFKB2,
REL, RELA, and RELB) and down-regulated expression of genes involved in
type I IFN responses (GBP1, IFI16, IFI27, IFI27L1-2, IFI30, IFI35, IFI44, IFI44L,
IFI6, IFIH1, IFIT1-3, IFIT5, IFIT1L, IFITM1-3, IFITM4P, IFITM5, IFNB1, IRF2, IRF7-8,
MX1-2, OAS1-3, and OASL) and antibody synthesis (IGJ, IGLL1, and IGLL3)
(12, 33). To identify transcription control pathways that may mediate ob-
served transcriptional differences, initial “low-level” genome-wide analyses
identified all transcripts showing a point estimate of ≥1.5-fold differential
expression across the range −2 SD to +2 SD relative to mean levels of
eudaimonic and hedonic well-being (each adjusted for the other and for the
covariates listed earlier), and those putatively associated genes were subject
to TELiS promoter-based bioinformatic analysis (40) to assess activity of NF-
κB, AP-1, IRF, and STAT family transcription factors previously linked to CTRA
transcriptional dynamics (TRANSFAC V$CREL_01, V$AP1_Q4, V$IRF1_01,
V$IRF2_01, V$STAT_01) (40), with results averaged over nine parametric var-
iations of MatInspector scan stringency and promoter length (65). TOA was
applied to the low-level association data to identify the specific PBMC sub-
types mediating the observed differences in gene expression, as previously
described (36). Low-level transcript-phenotype associations (Datasets S1 and
S2) were estimated solely as inputs into high-level TELiS and TOA gene set
expression analyses and are not tested for statistical reliability at the level of
individual genes. Split-half replication studies and Monte Carlo power
analyses were conducted to verify replicability of high-level associations of
a priori-defined CTRA-related gene sets with phenotypes (SI Methods and
Figs. S1–S7). Additional analytic details are provided in SI Methods.
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